Cellmid 2018 Annual Report
Accounting Policy
Identification of reporting segments
The Group is organised into two operating segments:
• Midkine Business; research and development of diagnostics and therapeutics; and
• Consumer Health Business; research, development and marketing of hair care products.
These operating segments are based on the internal reports that are reviewed and used by the Board of Directors (identified as
the Chief Operating Decision Makers (CODM)) in assessing performance and in determining the allocation of resources. There
is no aggregation of operating segments. The CODM review both adjusted earnings before interest, tax, depreciation and
amortisation (segment result) and loss before income tax.
Types of products and services
The principal products and services of each of these operating segments are as follows:
Research and development of diagnostics and therapeutics (Midkine Business)
• Midkine diagnostics and therapeutics for cancer, inflammatory and ischemic conditions.
Research, development and marketing of hair care products (Consumer Health Business)
• research, development and marketing of hair care products.
On 30 June 2018 the Group presented both business and geographical segments. The presentation of business segments is
to ensure that segment information is in line with the internal reports presented to the Board of Directors. The Group presents
USA and Australia as one segment due to the trading activity in the US company being minor to the Group and launch
expenses being absorbed within the Australian operations.